Controlled plasmid delivery and gene expression : applications for nucleic Acid-based vaccines

Area of Science:

• Immunology
• Vaccinology
• Molecular Biology

Background:

• Genetic immunization, first shown in 1992, has spurred research into nucleic acid-based vaccines.
• These vaccines show promise for preventing and treating infectious diseases.
• They mimic immune responses seen with attenuated or whole-killed viral vaccines.

Purpose of the Study:

• To review the efficacy and safety of nucleic acid-based vaccines.
• To compare nucleic acid-based vaccines with conventional vaccine types.
• To address theoretical safety concerns associated with this technology.

Main Methods:

• Review of existing studies on nucleic acid-based vaccines.
• Analysis of immune responses (cellular and humoral) elicited by these vaccines.
• Evaluation of synthesis, production, and safety profiles.

Main Results:

• Nucleic acid-based vaccines are effective short-term and provide prolonged anamnestic responses up to one year.
• They induce broader immune responses (cellular and humoral) compared to subunit vaccines.
• Production is relatively easy, and safety concerns like viral contamination or reversion are avoided.

Conclusions:

• Nucleic acid-based vaccines present a promising alternative to conventional vaccines.
• While theoretical safety concerns exist (e.g., plasmid integration), current evidence does not support severe adverse effects from naked plasmid administration.
• Further research into safety and efficacy is warranted.